Upfront triple combination therapy with selexipag: insights from a real world cohort in Chinese patients with pulmonary arterial hypertension.

Front Cardiovasc Med · 2026 · PMC13233463 · PMID 42257035

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In our previous exploratory study with a small sample size, although the triple combination with selexipag improved risk status, the reduction in RAA did not reach statistical significance ( 9 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.